Jefferies Group reiterated their hold rating on shares of Analogic (NASDAQ:ALOG) in a research report released on Friday. Jefferies Group currently has a $80.00 price target on the medical research company’s stock. Jefferies Group also issued estimates for Analogic’s Q2 2018 earnings at $0.68 EPS, Q3 2018 earnings at $0.76 EPS, Q4 2018 earnings at $0.66 EPS, FY2018 earnings at $2.86 EPS, FY2019 earnings at $3.00 EPS, FY2020 earnings at $3.25 EPS, FY2021 earnings at $3.40 EPS and FY2022 earnings at $3.57 EPS.

Other analysts have also issued research reports about the company. BidaskClub lowered Analogic from a hold rating to a sell rating in a report on Thursday. Zacks Investment Research raised Analogic from a hold rating to a buy rating and set a $97.00 target price for the company in a report on Friday. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company’s stock. Analogic presently has an average rating of Hold and a consensus target price of $88.33.

Analogic (NASDAQ ALOG) opened at $86.00 on Friday. Analogic has a 52-week low of $66.00 and a 52-week high of $88.45. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.58 and a current ratio of 5.82. The firm has a market capitalization of $1,073.71, a P/E ratio of 44.10, a P/E/G ratio of 4.30 and a beta of 0.86.

Analogic (NASDAQ:ALOG) last posted its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.43 by $0.32. The company had revenue of $106.90 million during the quarter, compared to analyst estimates of $100.55 million. Analogic had a positive return on equity of 5.09% and a negative net margin of 15.06%. The firm’s revenue for the quarter was down 11.7% on a year-over-year basis. During the same quarter last year, the company earned $0.43 EPS. equities analysts forecast that Analogic will post 2.86 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend is Thursday, December 14th. Analogic’s payout ratio is -6.99%.

Hedge funds have recently added to or reduced their stakes in the company. Flinton Capital Management LLC boosted its stake in shares of Analogic by 100.0% in the 2nd quarter. Flinton Capital Management LLC now owns 1,768 shares of the medical research company’s stock worth $129,000 after buying an additional 884 shares during the last quarter. State Board of Administration of Florida Retirement System purchased a new position in shares of Analogic in the 3rd quarter worth $224,000. Piedmont Investment Advisors LLC purchased a new position in shares of Analogic in the 3rd quarter worth $227,000. Crossmark Global Holdings Inc. purchased a new position in shares of Analogic in the 3rd quarter worth $250,000. Finally, Oppenheimer & Co. Inc. purchased a new position in shares of Analogic in the 2nd quarter worth $263,000. Hedge funds and other institutional investors own 97.61% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Receive News & Ratings for Analogic Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Co. and related companies with's FREE daily email newsletter.